These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31496051)

  • 1. HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study.
    Yotebieng M; Mpody C; Ravelomanana NL; Tabala M; Malongo F; Kawende B; Ntangu P; Behets F; Okitolonda E;
    J Int AIDS Soc; 2019 Sep; 22(9):e25376. PubMed ID: 31496051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study.
    Mpody C; Thompson P; Tabala M; Ravelomanana NLR; Malongo F; Kawende B; Behets F; Okitolonda E; Yotebieng M;
    PLoS One; 2019; 14(5):e0216293. PubMed ID: 31071145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous quality improvement interventions to improve long-term outcomes of antiretroviral therapy in women who initiated therapy during pregnancy or breastfeeding in the Democratic Republic of Congo: design of an open-label, parallel, group randomized trial.
    Yotebieng M; Behets F; Kawende B; Ravelomanana NLR; Tabala M; Okitolonda EW
    BMC Health Serv Res; 2017 Apr; 17(1):306. PubMed ID: 28446232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
    Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
    Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C prevalence and quality of health services among HIV-positive mothers in the Democratic Republic of the Congo.
    Thompson P; Mpody C; Sayre W; Rigney C; Tabala M; Ravelomanana NLR; Malongo F; Kawende B; Behets F; Okitolonda E; Yotebieng M;
    Sci Rep; 2022 Jan; 12(1):1384. PubMed ID: 35082320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
    PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
    Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of HIV testing among pregnant and breastfeeding women and risk of mother-to-child HIV transmission in Malawi: a sampling-based cohort study.
    Chagomerana MB; Edwards JK; Zalla LC; Carbone NB; Banda GT; Mofolo IA; Hosseinipour MC; Herce ME
    J Int AIDS Soc; 2021 Mar; 24(3):e25687. PubMed ID: 33749155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of comprehensiveness of antiretroviral care and detectable HIV viral load suppression among pregnant and postpartum women in the Democratic Republic of the Congo: a cross-sectional study.
    Boisson-Walsh A; Ravelomanana NLR; Tabala M; Malongo F; Kawende B; Babakazo P; Yotebieng M
    Front Glob Womens Health; 2024; 5():1308019. PubMed ID: 38903153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa.
    Moyo F; Mazanderani AH; Kufa T; Sherman GG
    S Afr Med J; 2021 Apr; 111(5):469-473. PubMed ID: 34852890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
    Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.
    Ntombela NP; Kharsany ABM; Soogun A; Yende-Zuma N; Baxter C; Kohler HP; McKinnon LR
    Reprod Health; 2022 May; 19(1):116. PubMed ID: 35550580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
    Yotebieng M; Thirumurthy H; Moracco KE; Edmonds A; Tabala M; Kawende B; Wenzi LK; Okitolonda EW; Behets F
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S124-9. PubMed ID: 27355499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo.
    Zotova N; Familiar I; Kawende B; Kasindi FL; Ravelomanana N; Parcesepe AM; Adedimeji A; Lancaster KE; Kaba D; Babakazo P; Yotebieng M
    J Int AIDS Soc; 2022 Feb; 25(2):e25865. PubMed ID: 35129301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
    Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of unsuppressed viral load among pregnant and breastfeeding women in sub-Saharan Africa: analysis from population-based surveys.
    Schrubbe LA; Stöckl H; Hatcher AM; Marston M; Kuchukhidze S; Calvert C
    AIDS; 2023 Mar; 37(4):659-669. PubMed ID: 36511117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa.
    Woldesenbet SA; Kufa T; Barron P; Chirombo BC; Cheyip M; Ayalew K; Lombard C; Manda S; Diallo K; Pillay Y; Puren AJ
    AIDS; 2020 Mar; 34(4):589-597. PubMed ID: 31821189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.